(Date:7/3/2009)...nt-resistant strain, study finds , , ...esistant tuberculosis might someday meet its match...e, suggests a new study. , Researchers, led b...ego, report in the July 3 issue of PLoS Computati...ne and tolcapone have the potential to treat the d...
(Date:7/3/2009)...USNewswire/ -- Republicans on the Senate Finance C...eform legislation that would eliminate coverage fo...ould lose coverage for abortion services that thei...ions of uninsured women will still lack a basic he...etter quality of life. , , If these senators ar...
(Date:7/3/2009)...nies and three individuals have been recognized fo...onal competition designed to reward workplace heal...XChange.org community released its 2009 Saxcies gl....safetyxchange.org/saxcies-video . The winners and... their lives to keeping others safe - are detailed...
(Date:7/3/2009)...omeCare, a home medical services provider speciali...y and DME services, is expanding. Two new pharmaci...n home infusion therapy and one in oral medication... Clinton, NY (PRWEB) June 22, 2... provider specializing in infusion, specialty medi...
Breaking Medicine News(10 mins):Health News:New Weapons in Fight Against TB? 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3...min E may be effective in restoring sudden onset h...occurs within three days or less. The cause of th... 10 percent to 15 percent of the cases, which incl... neurologic and immunologic sources. The rest of t...
...t pregnant women are at a higher risk of developin...s marked by // an urge to move the legs and is gen...g or burning sensations. Patients also report an i...rary relief from symptoms through activity, and a ...
...ken at Wake Forest University Baptist Medical Cent...ns after research in monkeys suggested //that the ...t affect heart attack severity. At an annual mee...ociety in Washington, D.C. today, Dr. J. Koudy Wil...
...t pregnant women are at a higher risk of developin...s marked by // an urge to move the legs and is gen...g or burning sensations. Patients also report an i...rary relief from symptoms through activity, and a ...
Other Medicine News:Health News:Hormone therapy may affect heart attack severity in women 2(Date:6/28/2009)...CORONADO, Portugal, June 29 Data p...d-on treatment with the novel,once-daily anti-ep... resulted,in a marked and sustained decrease in s...esults from the one-year extension of a pivotal Es...ted at the International Congress for Epilepsy in,...
(Date:6/26/2009)..., June 26 Sanofi-avent...made aware of data associated with a retrospective... of these data clearly show that no definitive con...relationship between Lantus(R) (insulin glargine [...ncies, as the authors of the study point out. , ...
(Date:6/26/2009)...Recommends Approval of New Anti-TNF Therapy in Thr...oinjector , , HORSHAM, Pa. and KENILWORTH, N.J.... Biotech Inc. and Schering-Plough Corporation (NYS...Medicinal Products for Human Use (CHMP) of the Eur...pinion recommending the approval of SIMPONI(TM) (g...
(Date:6/25/2009)...June 25 "Congratulations President... companies to cut prescription costs for the elder...ompany, Inc. "We thought you should know that you ...e same for psoriasis sufferers of all ages." , ,...Inc., and the submission of their findings from a ...
Breaking Medicine Technology:Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform 2Anti VEGF drugs for retinal diseases could have serious side effects scientists caution 28569 1Anti VEGF drugs for retinal diseases could have serious side effects scientists caution 28569 2Anti VEGF drugs for retinal diseases could have serious side effects scientists caution 28569 3Vineland Welcomes Dr Isabelle Lesschaeve as Research Chair Sensory and Consumer Sciences 8831 1Vineland Welcomes Dr Isabelle Lesschaeve as Research Chair Sensory and Consumer Sciences 8831 2Younger People Not Seniors Getting More Colds and Feeling Run Down 28566 1Younger People Not Seniors Getting More Colds and Feeling Run Down 28566 2RainDance Technologies to Present Sequence Enrichment Using Droplet Based Microfluidics Workshop at ASHG 2008 8830 1RainDance Technologies to Present Sequence Enrichment Using Droplet Based Microfluidics Workshop at ASHG 2008 8830 2...enous Antihypertensives,to Date Presented at ACC S...RNewswire-FirstCall/ -- Findings,from ECLIPSE**, t...tihypertensive therapies, show that improved contr...harmful elevation in,blood pressure just before, d...ing cardiac surgery is strongly associated with a,...
.../ -- Afid,Therapeutics, Inc. announced that it rec...riple mode viral sequestration agents to,block vir...lts were,obtained from a specialized, independent ...questrating agents are designed to,bind and inacti...g,infection. They are aimed at viruses responsible...
Other Medicine Technology:Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 2Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 3Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 4Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents 2Standard 20x long working distance objectives for greater magnifications of your microtools.
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
The CKX microscopes utilize the infinity-corrected optical system for improved visibility and operability in cell checking. The CKX31 is a cost-effective inverted microscope suited to routine applica
The Eclipse TE2000U is an advanced inverted microscope for live cell microscopy. Its exclusive CFI60 optical system, extendible design and advanced features make it ideal for high precision, multi-mo
Medicine Products: